Skip to main content

Site notifications

CABENUVA cabotegravir 400 mg/2 mL plus rilpivirine 600 mg/2 mL prolonged-release suspensions for injection vials (2024-25)

Product name
CABENUVA cabotegravir 400 mg/2 mL plus rilpivirine 600 mg/2 mL prolonged-release suspensions for injection vials
Sponsor name
ViiV Healthcare Pty Ltd
Year Range
2024-25